Inify Laboratories
Kate Bucknall is currently the Business Development Director at Inify Laboratories. Prior to this, Kate has held key roles such as the Global Marketing Director at OssDsign and Director at DeviceMed Consulting. With a background in pharmacology and medicine & surgery, Kate has extensive experience in commercial strategy, market research, product development, and training within the healthcare industry. Throughout their career, Kate has demonstrated strong leadership and expertise in driving growth and market expansion for various companies.
This person is not in any offices
Inify Laboratories
Inify Laboratories provides cancer diagnostics through ultramodern laboratory services within pathology. It uses a fully digital, standardized and AI- supported workflow to optimize quality and response times, initially within prostate. The concept is scalable and can be extended to other diagnoses. The service includes the whole chain of sample handling: from logistics, to sample preparation, to reporting by a pathologist from either Inify Laboratories or the customer’s organization. The report is assisted by our own AI, proven in clinical studies to have world-leading accuracy. The complete workflow is supported by a tailor-made process control system. The company, based in Sweden, became independent in 2022 through a spin-off from ContextVision, with 40 years of experience within digital imaging for medical applications. It is listed on Euronext Growth Oslo under the ticker INIFY.